Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Combating Cardiovascular Disease With Compounded Medications. Part 1: Combination Cardiac Medicines to Control Blood Pressure

Author(s):  Harrington Catherine A, Cauffield Jacintha

Issue:  Mar/Apr 2005 - Health and Wellness
View All Articles in Issue

Page(s):  117-119

Combating Cardiovascular Disease With Compounded Medications. Part 1: Combination Cardiac Medicines to Control Blood Pressure Page 1
Combating Cardiovascular Disease With Compounded Medications. Part 1: Combination Cardiac Medicines to Control Blood Pressure Page 2
Combating Cardiovascular Disease With Compounded Medications. Part 1: Combination Cardiac Medicines to Control Blood Pressure Page 3

Download in electronic PDF format for $65

Abstract:  Findings from recent studies have shown that cardiovascular disease is best controlled through a combination of blood pressure and other cardiac medications. Most patients with hypertension, for example, need at least three drugs to control their blood pressure and usually take a cholesterol-lowering drug as well. Combine this with the need for medicines for other common symptomatic conditions, such as acid reflux, allergy, depression, and osteoarthritis, and a relatively “healthy” adult could easily be taking five or more medicines per day. Compounding pharmacists have an ideal opportunity to work with prescribers to simplify drug-taking regimens by combining multiple cardiac drugs into a single capsule, thereby increasing treatment flexibility (no fixed doses), decreasing side effects (with lower doses), and most likely decreasing drug costs. The benefits for compliance could be tremendous. Clinical and pharmaceutical issues to resolve include preferred formulations based on clinical trial evidence, starting doses, tolerability of dosage forms, stability, interactions between drugs or with excipients, and the incorporation of extended-release brand drugs. Part 2 in this series will begin to address these questions.

Related Keywords: Catherine A. Harrington, PharmD, PhD, Jacintha Cauffield, PharmD, BCPS, cardiovascular disease, hypertension, heart disease, antihypertensive agents, statins, folic acid, aspirin, blood pressure, cholesterol level, homocysteine, platelet function, prevention, polypill

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Combating Cardiovascular Disease With Compounded Medications. Part 1: Combination Cardiac Medicines to Control Blood Pressure
Harrington Catherine A
, Cauffield Jacintha
Mar/Apr 2005
Pg. 117-119

Combating Cardiovascular Disease with Compounded Medications -- Part 2: Clinical and Compounding Issues for Antihypertensive Drugs
Harrington Catherine A
, Cauffield Jacintha
May/Jun 2005
Pg. 201-205

The Treatment of Canine Atopic Disease
Davidson Gigi S
May/Jun 2002
Pg. 210-215

Basics of Compounding for Raynaud's Disease
Glasnapp Andrew
Jul/Aug 2003
Pg. 288-291

Treating Canine Hepatic Disease
Davidson Gigi S
May/Jun 2003
Pg. 188-191

Coenzyme Q10 Supplementation in the Treatment of Heart Disease
Bramwell Bethany L
Mar/Apr 2010
Pg. 108-111

Impact of Conventional and Bioidentical Hormone Replacement Therapy on Cardiovascular and Breast Health: A Review
Ruiz Andres D
, Daniels Kelly R, Barner Jamie C, Carson John J, Frei Christopher R
Jul/Aug 2011
Pg. 290-300

Compounding for Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Diseases
Harrington Amy
, Williams LaVonn
Jul/Aug 2022
Pg. 293-296

Wetting and/or Solubilizing Agents, Featured Excipient:
Allen Loyd V Jr
Jul/Aug 2001
Pg. 310-312

Acidifying Agents, Featured Excipient:
Allen Loyd V Jr
Jul/Aug 1999
Pg. 309-310

Particle Measuring Systems - USP <797> Environmental Monitoring Solutions